Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04169282 · ClinicalTrials.gov registry record · NA

PEEP Mask for Tracheobronchomalacia-Induced Cough

A NA study, sponsored by Duke University.

Completed
Registry status
NA
Development phase
10
Enrollment target

NCT04169282: Completed NA study, sponsored by Duke University.

NCT04169282 is a NA study that has completed, run by Duke University. The registered enrollment target is 10 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04169282, a NA study, has completed, sponsored by Duke University.

COMPLETED
Registry status
NA
Development phase
10 participants
Enrollment target

Study Summary

This study aims to determine if an expiratory resistance device that delivers non-invasive positive expiratory pressure (nPEP) will reduce or stop coughing, reduce airway resistance and improve quality of life in patients with tracheobronchomalacia (TBM) who are not candidates for tracheal stenting.

Primary Outcome

The primary objective is to determine if use of the nPEP device will change cough severity. Responses to the Cough VAS range from 0-100 mm, with higher scores corresponding to worse outcomes.

Interventions

  • DEVICE nPEP (non-invasive positive expiratory pressure) mask

Trial Details

FieldValue
Enrollment Target 10 participants
Start Date 2021-08-30
Est. Completion 2022-08-15
Phase NA
Duke University

1,725 total trials

What the finished NCT04169282 record still lists

NCT04169282 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 10 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).

The record links to 0 conditions, and to 1 intervention - of which nPEP (non-invasive positive expiratory pressure) mask is the first listed.

NCT04169282 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT04169282 about?

NCT04169282 is a clinical study titled "PEEP Mask for Tracheobronchomalacia-Induced Cough". This study aims to determine if an expiratory resistance device that delivers non-invasive positive expiratory pressure (nPEP) will reduce or stop coughing, reduce airway resistance and improve quality of life in patients with tracheobronchomalacia (TBM) who are not candidates for tracheal stenting.

What is the current status of trial NCT04169282?

This trial is currently completed. It is a NA study. The enrollment target is 10 participants. The study started on 2021-08-30. Estimated completion is 2022-08-15.

What interventions are being tested in trial NCT04169282?

The interventions under investigation include: nPEP (non-invasive positive expiratory pressure) mask (DEVICE).

Who is sponsoring clinical trial NCT04169282?

This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT04169282's enrollment target sits among peer trials

10 1927th of 2000 higher than 26 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00623389 · 10 participants · NA

    Evaluation of an Advanced Lower Extremity Neuroprostheses

  • NCT01241864 · 10 participants · Phase 2

    Islet Transplantation in Type 1 Diabetic Kidney Allograft

  • NCT01293214 · 10 participants · NA

    Vascularized Composite Allotransplantation for Multiple Extremity Amputations

  • NCT01474148 · 10 participants · NA

    A Neuroprosthesis for Seated Posture and Balance

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04169282, the US trial registry maintained by the National Library of Medicine. NCT04169282 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.